The aim of this prospective study is investigation of efficiency and safety of medical device "Magic Gyno" in accordance with the stated purpose. To assess the condition of the vaginal walls and vulva before and after laser treatment, the following methods will be used: gynecology examination, vaginal health index, clinical blood test, vaginal flora examination, vaginal pH. International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF), Female Sexual Function Index (FSFI) and The Short Form Health Survey (SF-36) will be used to collect feedback on changes in the participants life quality. Total up to 70 participants with pathology of pelvic organs will be involved in the study. Participants will be divided into two groups: group with genitourinary symptoms and group with vaginal relaxation symptoms, by 35 participants in each. The time intervals between tests will be the same for both groups. The main hypothesis of the study is improvement in condition of the vaginal walls after laser treatment compared with the condition before treatment.
No linked publications found in PubMed
Inclusion Criteria: * Women from 18 years old in conditions caused by collagen deficiency in the treated area, women in premenopause and menopause; * Participants who signed informed consent and fully informed about the purpose of the study; Following disorders: * Stress urinary incontinence, * Mixed urinary incontinence with a predominance of the stress component, * Genitourinary menopausal syndrome, * Dystrophic and atrophic processes in the genital area, * Scleroatrophic changes in the urogenital region, * Prolapse of the genitals I-II degree, * Vaginal relaxation syndrome, * Postpartum recovery, * Sexual dysfunctions, * Restoration of tone, turgor and tissue density of the urogenital area (Intimate rejuvenation, correction of age-related changes), * Preoperative preparation for genital prolapse surgery and postoperative rehabilitation. Exclusion Criteria: * Age up to 18 years; * Inability or unwillingness to give informed consent to participate in a trial or to fulfill the requirements of a clinical trial; * The presence of contraindications to the use of a medical device; * Pregnancy; * Bleeding disorders accompanied by a violation of blood clotting; * Use of anticoagulant medicines (post-infarction and post-stroke conditions); * Autoimmune diseases; * Emerging infection diseases of any etiology; * Damage to the skin (mucous membranes) in the area of laser treatment; * Oncological diseases, cancer alertness; * Decompensated diabetes; * Photosensitizing drug administration; * Decompensated somatic diseases; * Decompensated cardiovascular disease, and other decompensated common diseases; * Severe somatic diseases (heart failure, chronic renal failure, hepatitis, liver cirrhosis); * Severe autoimmune diseases (including hemorrhagic vasculitis); * Immunodeficiency (including HIV infection and AIDS); * Severe mental and neurological disorders; * Bedridden and immobile patients; * COVID 19; * Acute inflammatory diseases of the urogenital area; * Acute purulent processes of the urogenital region; * Bleeding of a natural nature (menstruation) and any other types of bleeding in the urogenital area; * Postoperative scars up to 6 months; * Lateral cysts of the vagina; * Growing uterine fibroid; * Fillers / suture in the area of laser exposure; * The presence of varicose veins of the urogenital region and dilated capillary plexuses of the mucosa.